Related Experiment Video
Updated: Aug 9, 2025
07:43
Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
Published on: May 3, 2024
3.0K
Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression
Ziyue Wang1, Zixin Zeng2, Feng Gao3
1Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
BMC Medical Genomics
|February 21, 2023
Summary
This study identified STC2 as a key gene in osteosarcoma development. Increased STC2 expression is linked to poorer patient survival, suggesting its potential as a diagnostic and therapeutic target for this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Osteosarcoma is the most common primary bone malignancy in children and adolescents.
- Understanding its genetic basis is crucial due to its heterogeneous nature.
- Identifying novel genes can improve diagnosis and treatment strategies.
Purpose of the Study:
- To identify novel genes involved in osteosarcoma development.
- To find potential gene indicators for precise disease interpretation.
- To explore the role of identified genes in osteosarcoma pathogenesis.
Main Methods:
- Differential gene expression analysis using GEO database microarrays.
- Gene Ontology (GO) and KEGG pathway analysis.
- Survival analysis, risk score assessment, and validation using IHC and qRT-PCR.
Main Results:
- Identified differentially expressed genes (DEGs) in osteosarcoma vs. normal bone.
- A 22-gene cluster related to extracellular matrix regulation was found.
- STC2 emerged as an independent prognostic indicator, with validated increased expression in osteosarcoma tissues.
Conclusions:
- STC2 expression is significantly associated with osteosarcoma patient survival.
- Explored STC2's clinical features and potential biological functions.
- STC2 shows promise as a potential drug target, warranting further clinical investigation.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K